A Phase 2 interventional study of Placebo and Brimonidine tartrate 0.025% in Ocular Redness, sponsored by Eye Therapies, LLC. Completed at 1 site in United States. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-07-31.
Sponsored by Eye Therapies, LLC · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects
Eye Therapies, LLC is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Placebo
Drug: Brimonidine tartrate 0.025%
1 drop in each eye daily for up to 35 days
1 drop in each eye for up to 35 days
Ocular redness
redness evaluated by investigator prior to study medication instillation and redness evaluated by the subject as captured in dosing diary
Time frame: at specified timepoints for up to 180 minutes
Ocular Redness
evaluated prior to study medication instillation and at 5 minutes post instillation
Time frame: up to 5 minutes post study medication instillation
The record gives a start of Aug 2012 and a primary completion of Oct 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Brimonidine
Eye Therapies, LLC